New insights into subclinical hypothyroidism and cardiovascular risk

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 1, 2011, Pages 27-34

  Duntas, Leonidas H ^a   Biondi, Bernadette ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

cardiovascular risk; hemostasis; Subclinical hypothyroidism; TSH

Indexed keywords

C REACTIVE PROTEIN; GLUCAGON; LEPTIN; LEVOTHYROXINE; LIOTHYRONINE; RETINOL BINDING PROTEIN 4; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ANTIBODY BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BLEEDING TIME; BLOOD CLOTTING TIME; BLOOD PRESSURE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENERGY EXPENDITURE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GLUCAGON RELEASE; HEART FAILURE; HEART INFARCTION; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; HYPERLIPIDEMIA; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; LIPID METABOLISM; MORTALITY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SUBCLINICAL HYPOTHYROIDISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ANIMALS; CARDIOVASCULAR DISEASES; HEMOSTASIS; HUMANS; HYPOTHYROIDISM; RISK FACTORS; THYROXINE;

EID: 79251488793     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1270068     Document Type: Article

References (75)

1. Biondi B, Cooper D S. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008 29 1 76-131
2. Tunbridge W M., Evered D C., Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977 7 6 481-493
3. Hollowell J G., Staehling N W., Flanders W D. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002 87 2 489-499
4. Canaris G J., Manowitz N R., Mayor G, Ridgway E C. The Colorado thyroid disease prevalence study. Arch Intern Med 2000 160 4 526-534
5. Duntas L H., Wartofsky L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid 2007 17 11 1075-1084
6. Li Y, Shan Z, Teng W et al. Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf) 2010 72 6 825-829
7. Vanderpump M P., Tunbridge W M., French J M. et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995 43 1 55-68
8. Duntas L H. Subclinical hypothyroidism: a misnomer in search of a new name. Thyroid 2001 11 4 361-362
9. Surks M I., Ortiz E, Daniels G H. et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004 291 2 228-238
10. Boucai L, Surks M I. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf) 2009 70 5 788-793
11. Karmisholt J, Andersen S, Laurberg P. Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism. Thyroid 2008 18 3 303-308
12. Andersen S, Bruun N H., Pedersen K M., Laurberg P. Biologic variation is important for interpretation of thyroid function tests. Thyroid 2003 13 11 1069-1078
13. Vigrio P, Teixeira P, Reuters V et al. Perceived health status of women with overt and subclinical hypothyroidism. Med Princ Pract 2009 18 4 317-322
14. McMillan C, Bradley C, Razvi S, Weaver J. Evaluation of new measures of the impact of hypothyroidism on quality of life and symptoms: the ThyDQoL and ThySRQ. Value Health 2008 11 2 285-294
15. Fazio S, Palmieri E A., Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004 59 31-50
16. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 2004 24 1 1-13
17. Cappola A R., Ladenson P W. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003 88 6 2438-2444
18. Biondi B, Palmieri E A., Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002 137 11 904-914
19. Biondi B, Palmieri E A., Lombardi G, Fazio S. Subclinical hypothyroidism and cardiac function. Thyroid 2002 12 6 505-510
20. Biondi B, Fazio S, Palmieri E A. et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 1999 84 6 2064-2067
21. Brenta G, Mutti L A., Schnitman M, Fretes O, Perrone A, Matute M L. Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy. Am J Cardiol 2003 91 11 1327-1330
22. Rodondi N, Newman A B., Vittinghoff E et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005 165 21 2460-2466
23. Rodondi N, Bauer D C., Cappola A R. et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol 2008 52 14 1152-1159
24. Ripoli A, Pingitore A, Favilli B et al. Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol 2005 45 3 439-445
25. Nagasaki T, Inaba M, Kumeda Y et al. Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 2006 91 1 154-158
26. Owen P JD, Rajiv C, Vinereanu D, Mathew T, Fraser A G., Lazarus J H. Subclinical hypothyroidism, arterial stiffness, and myocardial reserve. J Clin Endocrinol Metab 2006 91 6 2126-2132
27. Taddei S, Caraccio N, Virdis A et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003 88 8 3731-3737
28. Hak A E., Pols H A., Visser T J., Drexhage H A., Hofman A, Witteman J C. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000 132 4 270-278
29. Imaizumi M, Akahoshi M, Ichimaru S et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab 2004 89 7 3365-3370
30. Walsh J P., Bremner A P., Bulsara M K. et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005 165 21 2467-2472
31. Vanderpump M P., Tunbridge W M. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002 12 10 839-847
32. Cappola A R., Fried L P., Arnold A M. et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006 295 9 1033-1041
33. Ochs N, Auer R, Bauer D C. et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 2008 148 11 832-845
34. Razvi S, Shakoor A, Vanderpump M, Weaver J U., Pearce S H. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab 2008 93 8 2998-3007
35. Gussekloo J, van Exel E, de Craen A J., Meinders A E., Frlich M, Westendorp R G. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004 292 21 2591-2599
36. van den Beld A W., Visser T J., Feelders R A., Grobbee D E., Lamberts S W. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab 2005 90 12 6403-6409
37. Klieverik L P., Coomans C P., Endert E et al. Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology 2009 150 12 5639-5648
38. Figueroa B, Vlez H, Irizarry-Ramrez M. Association of thyroid-stimulating hormone levels and body mass index in overweight Hispanics in Puerto Rico. Ethn Dis 2008 18 2, Suppl 2 S2-S151-4
39. Resta O, Pannacciulli N, Di Gioia G, Stefno A, Barbaro M P., De Pergola G. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis 2004 14 5 248-253
40. Asvold B O., Bjro T, Vatten L J. Association of serum TSH with high body mass differs between smokers and never-smokers. J Clin Endocrinol Metab 2009 94 12 5023-5027
41. Rotondi M, Leporati P, La Manna A et al. Raised serum TSH levels in patients with morbid obesity: is it enough to diagnose subclinical hypothyroidism? Eur J Endocrinol 2009 160 3 403-408
42. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010 316 2 165-171
43. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) 2007 67 2 265-269
44. Tagliaferri M, Berselli M E., Cal G et al. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 2001 9 3 196-201
45. Handisurya A, Pacini G, Tura A, Gessl A, Kautzky-Willer A. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf) 2008 69 6 963-969
46. Rodrigues A L., de Moura E G., Passos M C., Dutra S C., Lisboa P C. Postnatal early overnutrition changes the leptin signalling pathway in the hypothalamic-pituitary-thyroid axis of young and adult rats. J Physiol 2009 587 Pt 11 2647-2661
47. Ruhla S, Weickert M O., Arafat A M. et al. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf) 2010 72 5 696-701
48. Zimmermann M B., Aeberli I, Melse-Boonstra A et al. Iodine treatment in children with subclinical hypothyroidism due to chronic iodine deficiency decreases thyrotropin and C-peptide concentrations and improves the lipid profile. Thyroid 2009 19 10 1099-1104
49. Scarabottolo L, Trezzi E, Roma P, Catapano A L. Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liver. Atherosclerosis 1986 59 3 329-333
50. Duntas L H. Thyroid disease and lipids. Thyroid 2002 12 4 287-293
51. Brenta G, Berg G, Zago V et al. Proatherogenic mechanisms in subclinical hypothyroidism: hepatic lipase activity in relation to the VLDL remnant IDL. Thyroid 2008 18 11 1233-1236
52. Kim C S., Kang J G., Lee S J. et al. Relationship of low-density lipoprotein (LDL) particle size to thyroid function status in Koreans. Clin Endocrinol (Oxf) 2009 71 1 130-136
53. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver J U. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 2007 92 5 1715-1723
54. Monzani F, Caraccio N, Kozkow M et al. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. J Clin Endocrinol Metab 2004 89 5 2099-2106
55. Danese M D., Ladenson P W., Meinert C L., Powe N R. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000 85 9 2993-3001
56. Palmieri E A., Fazio S, Lombardi G, Biondi B. Subclinical hypothyroidism and cardiovascular risk: a reason to treat? Treat Endocrinol 2004 3 4 233-244 (Pubitemid 38924090)
57. Christ-Crain M, Meier C, Guglielmetti M et al. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 2003 166 2 379-386
58. Kvetny J, Heldgaard P E., Bladbjerg E M., Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf) 2004 61 2 232-238
59. Tuzcu A, Bahceci M, Gokalp D, Tuzun Y, Gunes K. Subclinical hypothyroidism may be associated with elevated high-sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocr J 2005 52 1 89-94
60. Lee W Y., Suh J Y., Rhee E J., Park J S., Sung K C., Kim S W. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. Arch Med Res 2004 35 6 540-545
61. Burba I, Devanna P, Pesce M. When cells become a drug. Endothelial progenitor cells for cardiovascular therapy: aims and reality. Recent Patents Cardiovasc Drug Discov 2010 5 1 1-10
62. Shakoor S K., Aldibbiat A, Ingoe L E. et al. Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy. J Clin Endocrinol Metab 2010 95 1 319-322
63. Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr Rev 2007 65 5 251-256
64. Choi S H., Lee Y J., Park Y J. et al. Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance. J Clin Endocrinol Metab 2008 93 6 2313-2318
65. Franchini M, Montagnana M, Manzato F, Vescovi P P. Thyroid dysfunction and hemostasis: an issue still unresolved. Semin Thromb Hemost 2009 35 3 288-294
66. Squizzato A, Romualdi E, Bller H R., Gerdes V E. Clinical review: thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab 2007 92 7 2415-2420
67. Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) 2006 64 3 323-329
68. Mina A, Favaloro E J., Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Semin Thromb Hemost 2007 33 8 798-809
69. Mller B, Tsakiris D A., Roth C B., Guglielmetti M, Staub J J., Marbet G A. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 2001 31 2 131-137
70. Ermantas N, Guldiken S, Demir M, Tugrul A. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism. Clin Appl Thromb Hemost 2010 16 5 568-573
71. Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001 86 2 732-737
72. Chadarevian R, Jublanc C, Bruckert E et al. Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism. J Endocrinol Invest 2005 28 5 398-404
73. Gullu S, Sav H, Kamel N. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism. Eur J Endocrinol 2005 152 3 355-361
74. Jorde R, Figenschau Y, Hansen J B. Haemostatic function in subjects with mild subclinical hypothyroidism. The Troms study. Thromb Haemost 2006 95 4 750-751
75. Biondi B. Should we treat all subjects with subclinical thyroid disease the same way? Eur J Endocrinol 2008 159 3 343-345